Wockhardt Limited Cash Flow Conversion Efficiency
Wockhardt Limited cash flow conversion efficiency. Based on the latest financial reports, Wockhardt Limited (WOCKPHARMA) has a cash flow conversion efficiency ratio of -0.005x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-220.00 Million ≈ $-2.38 Million USD) by net assets (Rs46.57 Billion ≈ $503.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Wockhardt Limited (2005–2025)
Cash flow conversion efficiency of Wockhardt Limited from 2005 to 2025. This chart illustrates how Wockhardt Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wockhardt Limited (WOCKPHARMA) stock price for real-time trading data and today's change.
Wockhardt Limited Cash Flow Conversion Ratio Explained
Wockhardt Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Wockhardt Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wockhardt Limited ranked by their cash flow conversion efficiency. Also see Wockhardt Limited (WOCKPHARMA) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Downer Edi Ltd
AU:DOW
|
0.105x |
|
Minth Group Limited
F:M3I
|
0.033x |
|
China Minsheng Banking Corp. Ltd
F:GHFH
|
-0.001x |
|
SLM Corp
NASDAQ:SLM
|
-0.054x |
|
Kenon Holdings
NYSE:KEN
|
-0.005x |
|
Organización Soriana S. A. B. de C. V
MX:SORIANAB
|
0.047x |
|
Henan Zhongfu Industrial Co Ltd
SHG:600595
|
0.001x |
|
Multistrada Arah Sarana Tbk
JK:MASA
|
0.131x |
Annual Cash Flow Conversion Efficiency for Wockhardt Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Wockhardt Limited from 2005 to 2025. Review how much free cash does Wockhardt Limited generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs46.57 Billion ≈ $503.64 Million |
Rs-220.00 Million ≈ $-2.38 Million |
-0.005x | -107.90% |
| 2024-03-31 | Rs36.62 Billion ≈ $396.03 Million |
Rs2.19 Billion ≈ $23.68 Million |
0.060x | +43.14% |
| 2023-03-31 | Rs36.62 Billion ≈ $396.03 Million |
Rs1.53 Billion ≈ $16.55 Million |
0.042x | -57.49% |
| 2022-03-31 | Rs42.02 Billion ≈ $454.43 Million |
Rs4.13 Billion ≈ $44.66 Million |
0.098x | +228.63% |
| 2021-03-31 | Rs37.60 Billion ≈ $406.66 Million |
Rs-2.87 Billion ≈ $-31.07 Million |
-0.076x | -136.00% |
| 2020-03-31 | Rs30.57 Billion ≈ $330.65 Million |
Rs6.49 Billion ≈ $70.18 Million |
0.212x | +247.89% |
| 2019-03-31 | Rs30.05 Billion ≈ $324.94 Million |
Rs1.83 Billion ≈ $19.83 Million |
0.061x | +185.08% |
| 2018-03-31 | Rs31.98 Billion ≈ $345.84 Million |
Rs684.40 Million ≈ $7.40 Million |
0.021x | +129.53% |
| 2017-03-31 | Rs37.19 Billion ≈ $402.16 Million |
Rs-2.69 Billion ≈ $-29.14 Million |
-0.072x | -539.46% |
| 2016-03-31 | Rs43.43 Billion ≈ $469.66 Million |
Rs716.10 Million ≈ $7.74 Million |
0.016x | -82.07% |
| 2015-03-31 | Rs38.59 Billion ≈ $417.37 Million |
Rs3.55 Billion ≈ $38.39 Million |
0.092x | -76.84% |
| 2014-03-31 | Rs37.18 Billion ≈ $402.05 Million |
Rs14.76 Billion ≈ $159.66 Million |
0.397x | -29.92% |
| 2013-03-31 | Rs27.04 Billion ≈ $292.45 Million |
Rs15.32 Billion ≈ $165.72 Million |
0.567x | -29.62% |
| 2012-03-31 | Rs14.71 Billion ≈ $159.09 Million |
Rs11.84 Billion ≈ $128.08 Million |
0.805x | +41.30% |
| 2011-03-31 | Rs11.26 Billion ≈ $121.82 Million |
Rs6.42 Billion ≈ $69.41 Million |
0.570x | +347.19% |
| 2010-03-31 | Rs8.35 Billion ≈ $90.33 Million |
Rs-1.93 Billion ≈ $-20.82 Million |
-0.231x | -288.42% |
| 2009-03-31 | Rs10.18 Billion ≈ $110.06 Million |
Rs1.25 Billion ≈ $13.46 Million |
0.122x | -58.70% |
| 2008-03-31 | Rs12.74 Billion ≈ $137.73 Million |
Rs3.77 Billion ≈ $40.79 Million |
0.296x | +67.51% |
| 2007-03-31 | Rs10.66 Billion ≈ $115.32 Million |
Rs1.89 Billion ≈ $20.39 Million |
0.177x | -29.49% |
| 2006-03-31 | Rs8.16 Billion ≈ $88.26 Million |
Rs2.05 Billion ≈ $22.13 Million |
0.251x | -22.04% |
| 2005-03-31 | Rs6.17 Billion ≈ $66.68 Million |
Rs1.98 Billion ≈ $21.45 Million |
0.322x | -- |
About Wockhardt Limited
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH… Read more